You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Miricorilant


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Miricorilant?

Miricorilant is an investigational drug.

There have been 7 clinical trials for Miricorilant. The most recent clinical trial was a Phase 1 trial, which was initiated on November 4th 2020.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Weight Gain. The leading clinical trial sponsors are Corcept Therapeutics and [disabled in preview].

There are five US patents protecting this investigational drug and sixty international patents.

Recent Clinical Trials for Miricorilant
TitleSponsorPhase
Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of MiricorilantCorcept TherapeuticsPhase 1
Phase 1 Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MiricorilantCorcept TherapeuticsPhase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)Corcept TherapeuticsPhase 1

See all Miricorilant clinical trials

Clinical Trial Summary for Miricorilant

Top disease conditions for Miricorilant
Top clinical trial sponsors for Miricorilant

See all Miricorilant clinical trials

US Patents for Miricorilant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Miricorilant ⤷  Try a Trial Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome Corcept Therapeutics, Inc. (Menlo Park, CA) ⤷  Try a Trial
Miricorilant ⤷  Try a Trial Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists Corcept Therapeutics, Inc. (Menlo Park, CA) ⤷  Try a Trial
Miricorilant ⤷  Try a Trial Pyrimidine cyclohexyl glucocorticoid receptor modulators Corcept Therapeutics, Inc. (Menlo Park, CA) ⤷  Try a Trial
Miricorilant ⤷  Try a Trial Pyrimidine cyclohexyl glucocorticoid receptor modulators Corcept Therapeutics, Inc. (Menlo Park, CA) ⤷  Try a Trial
Miricorilant ⤷  Try a Trial Pyrimidine cyclohexyl glucocorticoid receptor modulators Corcept Therapeutics, Inc. (Menlo Park, CA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Miricorilant

Drugname Country Document Number Estimated Expiration Related US Patent
Miricorilant Australia AU2017210156 2036-01-19 ⤷  Try a Trial
Miricorilant Canada CA3011728 2036-01-19 ⤷  Try a Trial
Miricorilant European Patent Office EP3405101 2036-01-19 ⤷  Try a Trial
Miricorilant Spain ES2861524 2036-01-19 ⤷  Try a Trial
Miricorilant Israel IL260687 2036-01-19 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.